RxDoctor Payments Data

James Arthur, MD

Family Medicine · Cottonwood, AZNPI 1588680516

Payments from drug & device makers

$1,422in general payments, 2019–2025

Across 86 payments — averaging $16.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$257
  • Exact Sciences$178
  • Amgen$156
  • AstraZeneca$147
  • Novo Nordisk$132
  • Boehringer Ingelheim$123
  • plus $428 from 13 others

What the payments were for

  • Food & beverage$1,422100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,422 in reported general payments places this provider in the 75th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$280,406
Medicare patients
424
Services billed
7,242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide158$209,346
Humira(Cf) Pen Crohn's-Uc-HsAdalimumab11$196,233
EliquisApixaban104$113,805
XeljanzTofacitinib Citrate12$80,441
Trelegy ElliptaFluticasone/Umeclidin/Vilanter85$74,580
OzempicSemaglutide60$63,235
XareltoRivaroxaban26$43,360
TrulicityDulaglutide32$37,452
JardianceEmpagliflozin16$27,489
MyrbetriqMirabegron19$24,259
FarxigaDapagliflozin Propanediol13$22,700
JanuviaSitagliptin Phosphate19$16,417
Praluent PenAlirocumab16$13,742
OxycontinOxycodone Hcl23$13,626
Combivent RespimatIpratropium/Albuterol Sulfate18$11,832

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$51$246,799190 claims
PfizerEliquis, Xeljanz$257$194,246116 claims
GSKTrelegy Ellipta, Breo Ellipta$42$86,136107 claims
Novo NordiskOzempic$132$63,23560 claims
Johnson & JohnsonXarelto$70$43,36026 claims
Boehringer IngelheimJardiance, Combivent Respimat$123$39,32134 claims
AstraZenecaFarxiga, Symbicort$147$29,72029 claims
Astellas Pharma US IncMyrbetriq$67$24,25919 claims
MerckJanuvia$26$16,41719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Cottonwood

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →